Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Ikaria Acquires New Drug Application for Lucassin
March 31, 2010
Ikaria Holdings, Inc. announced Tuesday that it has acquired the New Drug Application
and the Investigational New Drug application to LUCASSIN (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership
of the drug in North America and Australia.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing